Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-20

FDA Approved: HEPARIN SODIUM — Supplemental Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Heparin Sodium from Gland Pharma Limited (ANDA205323). This action confirms continued availability of the generic an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

SUPPL AP for HEPARIN SODIUM (HEPARIN SODIUM)